The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...
6don MSN
Shares of the company were up 5.2% in extended trading. The spray, sold under the brand name neffy, will be dosed at 1 ...
The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in ...
The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for severe allergic reactions and anaphylaxis.
Neffy 1 mg is now approved by the FDA to treat pediatric patients who weigh 33 to 65 lbs. Neffy was first FDA-approved as a 2 ...
KHQA on MSN1d
Blessing Health introduces new FDA-approved nasal spray treatment for resistant depressionUp to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...
Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...
WGNO-TV New Orleans on MSN8d
Nasal spray recalled nationwide; risk of infection: FDA(WHTM) — The U.S. Food & Drug Administration (FDA) has announced the voluntary recall of a sinus nasal wash bottle system following a confirmed test result of microbial contamination. According to the ...
In a new study on mice, an experimental antibody treatment reduced the lingering after-effects of head injuries.
Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback